Beyond the ECG changes, the incidence of SAEs no more than licensed comparator vaccines Box 1. The public health impact of a Chagas disease vaccine. Box 2. Rationale for selection of Tc24 and ...

As a deliverable, the advancement in development of an urgently needed new medical intervention, a therapeutic vaccine for Chagas disease, one of the most important neglected tropical diseases in ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old. <li /> On track for launch in key European markets i ...

Katja Michael, Ph.D., an associate professor at the University of Texas at El Paso, has been named a senior member of the ...

Katja Michael, Ph.D., an associate professor at the University of Texas at El Paso, has been named a senior member of the ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old.On track for launch in key European markets in the first half of 2025. COPENHAGEN, Denmark, February 28, 2025 ...

Limited (BE) to expand access to Bavarian Nordic's chikungunya vaccine in low- and ... 3 European Centre for Disease Prevention and Control. Chikungunya worldwide overview. .. 4 Ribas Freitas AR, ...

VIMKUNYA is an adjuvanted VLP recombinant protein vaccine for active immunization for the prevention of disease caused by chikungunya virus ... 4 Ribas Freitas AR, Pinheiro Chagas AA, Siqueira AM, ...

About VIMKUNYA™ (Chikungunya Vaccine, Recombinant) VIMKUNYA is a vaccine for prevention of disease caused by chikungunya ... 5 Ribas Freitas AR, Pinheiro Chagas AA, Siqueira AM, Pamplona de ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...

Dr. Katja Michael is honored as the first female UTEP faculty to become a Senior Member of the National Academy of Inventors.